Please assess the completion status of the following clinical trial:

Trial Title: Tolerability and Efficacy of High Dose Escitalopram for the Treatment of Obsessive-Compulsive Disorder (OCD)

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~1. Men and women over 18 years of age~2. DSM IV-TR criteria for OCD~3. OCD associated with most distress or most interference in the patient's life as judged by the treating physician~4. Yale-Brown Obsessive Compulsive Scale (YBOCS) total score ≥ 16~Exclusion Criteria:~1. Other primary or co-primary psychiatric disorder which is more distressful for the patient then the OCD, as evaluated by investigator~2. Patients with any history of mania/bipolar disorder~3. Patients using medications which are contraindicated with the use of escitalopram~4. Known contraindication for the use of citalopram or escitalopram.~5. Unable to understand and give informed consent~6. Prominent suicidal ideation (2 points or more in the MADRS suicidal thoughts item)~7. Alcohol or substance dependence in the past 6 months~8. Major physical illness~9. Woman currently pregnant or less then 4 weeks after a childbirth, a woman lactating, or a woman of childbearing potential not using a medically accepted form of contraception.~10. Liver function abnormality~11. EKG abnormalities

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).